In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Pharmacological properties

The composition of anginovag combines substances of anti-inflammatory, analgesic, antibacterial and antiseptic action. a combination of these pharmacological properties provides a comprehensive pathogenetic therapy of inflammatory diseases of the upper respiratory tract and oral mucosa. the drug is presented in the form of a spray with a valve for spraying, which makes it convenient for use in the treatment of infections of the oropharynx.


Local treatment for infectious and inflammatory diseases of the oral cavity and upper respiratory tract: tonsillitis, pharyngitis, laryngitis, aphthous and ulcerative stomatitis, glossitis.


Apply to adults and children over the age of 13 years. Before use, if necessary, rinse your mouth and throat with warm boiled water. swab to remove necrotic plaque from the affected areas (ulcers, erosion). the first two days - 1-2 injections every 2-3 hours, then - 1 injection every 6 hours. The course of treatment is determined by the doctor individually, usually 5-7 days.


Increased individual sensitivity (allergy) to any of the components of the drug.

Side effects

Not described. individual intolerance and allergic reactions to the components of the drug are possible.

special instructions

Security measures at application. for proper use, it is recommended to place the bottle in an upright position so that the oral applicator is directed to the affected area (do not enter completely into the oral cavity). press the top of the cap from top to bottom. Do not remove the oral applicator from the vial after installation and use.

Use during pregnancy and lactation. The use of the drug during pregnancy and lactation is not contraindicated, but the advisability of taking is determined by the doctor depending on the prevalence of benefits over the potential risk of use. Do not exceed recommended doses.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. No data available.

Children. There is no experience with the use of the drug in children under the age of 13 years.


Interactions with other drugs have not been identified.


Cases of overdose are not registered.

Storage conditions

At a temperature not exceeding 30 ° C.

Tags: Angiovag